Daneshgar Nastaran, Liang Peir-In, Michels Christina J, Nester Carla M, Harshman Lyndsay A, Dai Dao-Fu
Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA, United States.
Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Front Pediatr. 2022 Mar 4;10:827466. doi: 10.3389/fped.2022.827466. eCollection 2022.
Coronavirus disease 2019 (COVID-19) may cause a wide spectrum of kidney pathologies. The impact of COVID-19 is unclear in the context of the complement system abnormalities, including C3 glomerulopathy (C3G). In this report, we describe a young adult receiving a kidney transplant for C3 glomerulopathy (C3G), a disorder of the alternative complement pathway. The patient developed a recurrent C3G ~7 months after transplantation. His post-transplant course was complicated by SARS-CoV-2 infection. There was a progression of glomerulonephritis, characterized by immune-complex mediated membranoproliferative glomerulonephritis pattern of injury with crescentic and necrotizing features, along with positive immunoglobulins, persistent IgM staining and the presence of cryoglobulinemia. COVID-19 may have aggravated the inherent complement dysregulation and contributed to cryoglobulinemia observed in this patient. Our study of 5 sequential kidney allograft biopsy series implicates that COVID-19 in this patient promoted a superimposed immune complex-mediated glomerulonephritis with membranoproliferative glomerulonephritis (MPGN) pattern and cryoglobulinemia, which was a potentiating factor in allograft loss. This work represents the first report of cryoglobulinemic GN after COVID-19.
2019冠状病毒病(COVID-19)可能导致多种肾脏病变。在包括C3肾小球病(C3G)在内的补体系统异常情况下,COVID-19的影响尚不清楚。在本报告中,我们描述了一名因C3肾小球病(C3G,一种替代补体途径的疾病)接受肾移植的年轻成年人。该患者在移植后约7个月出现复发性C3G。他的移植后病程因感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)而复杂化。出现了肾小球肾炎的进展,其特征为免疫复合物介导的膜增生性肾小球肾炎损伤模式伴新月体和坏死特征,同时伴有免疫球蛋白阳性、持续的IgM染色和冷球蛋白血症。COVID-19可能加剧了该患者固有的补体失调,并导致了冷球蛋白血症。我们对5个连续的同种异体肾活检系列的研究表明,该患者的COVID-19促使叠加了免疫复合物介导的、具有膜增生性肾小球肾炎(MPGN)模式和冷球蛋白血症的肾小球肾炎,这是同种异体肾丢失的一个增强因素。这项工作代表了COVID-19后冷球蛋白血症性肾小球肾炎的首例报告。